White Matter and Cerebral Metabolite Changes in Children Undergoing Treatment for Acute Lymphoblastic Leukemia: Longitudinal Study with MR Imaging and 1H MR Spectroscopy

Radiology

Volumn 229, Issue 3, 2003, Pages 659-669

  Chu, Winnie C W ^a   Chik, Ki Wai ^a   Chan, Yu Leung ^a   Yeung, David K W ^a   Roebuck, Derek J ^b   Howard, Robert G ^a   Li, Chi Kong ^a   Metreweli, Constantine ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Brain, white matter; Leukemia, in infants and children; Leukemia, therapy; Magnetic resonance (MR), spectroscopy; Methotrexate

Indexed keywords

ASPARAGINASE; CHOLINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; N ACETYLASPARTIC ACID; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BRAIN MATURATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CENTRAL NERVOUS SYSTEM METASTASIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; METABOLITE; MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADOLESCENT; BRAIN; BRAIN CHEMISTRY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHOTREXATE; PROSPECTIVE STUDIES;

EID: 0345446985     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2293021550     Document Type: Article

References (40)

1. Schroeder H, Garwicz S, Kristinsson J, Siimes MA, Wesenberg F, Gustafsson G. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology. Med Pediatr Oncol 1995; 25:372-378.
2. Evans AE, Gilbert ES, Zandstra R. The increasing incidence of central nervous system leukemia in children: Children's Cancer Study Group A. Cancer 1970; 26: 404-409.
3. West RJ, Graham-Pole J, Hardisty RM, Pike MC. Factors in pathogenesis of central-nervous-system leukaemia. BMJ 1972; 3:311-314.
4. Nesbit ME Jr, Sather HN, Robison LL, et al. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukemia: comparison of 1800 rad and 2400 rad: a report for Children's Cancer Study Group. Lancet 1981; 1:461-466.
5. Eden OB, Lilleyman JS, Richards S, Shaw MP, Peto J. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol 1991; 78:187-196.
6. Paakko E, Talvensaari K, Pyhtinen J, Lanning M. Late cranial MRI after cranial irradiation in survivors of childhood cancer. Neuroradiology 1994; 36:652-655.
7. Laitt RD, Chambers EJ, Goddard PR, Wakeley CJ, Duncan AW, Foreman NK. Magnetic resonance imaging and magnetic resonance angiography in long term survivors of acute lymphoblastic leukemia treated with cranial irradiation. Cancer 1995; 76:1846-1852.
8. Hill JM, Kornblith AB, Jones D, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998; 82: 208-218.
9. Lien HH, Blomlie V, Saeter G, Solheim O, Fossa SD. Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate. Radiology 1991; 179:547-550.
10. Allen JC, Rosen G, Mehta BM, Horten B. Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 1980; 64:1261-1273.
11. Wilson DA, Nitschke R, Bowman ME, Chaffin MJ, Sexauer CL, Prince JR. Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. Radiology 1991; 180:205-209.
12. Paakko E, Vainionpaa L, Lanning M, Laitinen J, Pyhtinen J. White matter changes in children treated for acute lymphoblastic leukemia. Cancer 1992; 70: 2728-2733.
13. Matsumoto K, Takahashi S, Sato A, et al. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy: an MR analysis. Int J Radiat Oncol Biol Phys 1995; 32:913-918.
14. Chan YL, Roebuck DJ, Yuen MP, et al. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis. Int J Radiat Oncol Biol Phys 2001; 50:759-763.
15. Bleyer WA. Leukoencepalopathy detectable by magnetic resonance imaging: much ado about nothing? Regarding Matsumoto et al, IJROBP 32:913-918;1995. Int J Radiat Oncol Biol Phys 1995; 32:1251-1252.
16. Kingma A, Mooyaart EL, Kamps WA, Nieuwenhuizen P, Wilmink JT. Magnetic resonance imaging of the brain and neuropsychological evaluation in children treated for acute lymphoblastic leukemia at a young age. Am J Pediatr Hematol Oncol 1993; 15:231-238.
17. Harila-Saari AH, Paakko EL, Vainionpaa LK, Pyhtinen J, Lanning BM. A longitudinal magnetic resonance imaging study of the brain in survivors of childhood acute lymphoblastic leukemia. Cancer 1998; 83:2608-2617.
18. Eden OB, Harrison G, Richards S, et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997: Medical Research Council Childhood Leukaemia Working Party. Leukemia 2000; 14:2307-2320.
19. Hann I, Vora A, Harrison G, et al. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 2001; 113:103-114.
20. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 1995: Berlin-Frankfurt-Munster. Leukemia 2000; 14:2205-2222.
21. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129:35-43.
22. van den Boogaart A, Howe FA, Rodrigues LM, Stubbs M, Griffiths JR. In vivo 31P MRS: absolute concentrations, signal-to-noise and prior knowledge. NMR Biomed 1995; 8:87-93.
23. Goldstein H. Multilevel statistical models. London, England: Edward Arnold, 1995.
24. Ochs JJ, Parvey LS, Whitaker JN, et al. Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy. J Clin Oncol 1983; 1:793-798.
25. Paakko E, Harila-Saari A, Vanionpaa L, Himanen S, Pyhtinen J, Lanning M. White matter changes on MR1 during treatment in children with acute lymphoblastoic leumemia: correlation with neuropsychological findings. Med Pediatr Oncol 2000; 35:456-461.
26. Jaffe N, Takaue Y, Anzai T, Robertson R. Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer 1985; 56:1356-1360.
27. Yim YS, Maboney DH Jr, Oshman DG. Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia. Cancer 1991; 67:2058-2061.
28. Ebner F, Ranner G, Slavc I, et al. MR findings in methotrexate-induced CNS abnormalities. AJNR Am J Neuroradiol 1989; 10:959-964.
29. Van der Knaap MS, va der Grond J, van Rijen PC, Faber JA, Valk J, Willemse K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990; 176:509-515.
30. Roser W, Hagberg G, Mader I, et al. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 1995; 33:811-817.
31. Davies SE, Newcombe J, Williams SR, MacDonald WI, Clark JB. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995; 64: 742-748.
32. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117:49-58.
33. Esteve F, Rubin C, Grand S, Kolodie H, Le Bas JF. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 1998; 40:279-286.
34. Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA. MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992; 13:1535-1543.
35. Waldrop SM, Davis PC, Padgett CA, Shapiro MB, Morris R. Treatment of brain tumours in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumour site. AJNR Am J Neuroradiol 1998; 19:963-970.
36. Kramer JH, Norman D, Brant-Zawadzki M, Ablin A, Moore IM. Absence of white matter changes on magnetic resonance imaging in children treated with CNS prophylaxis therapy for leukemia. Cancer 1988; 61:928-930.
37. Rajanayagam V, Grad J, Krivit W, et al. Proton MR spectroscopy of childhood adrenoleukodystrophy. AJNR Am J Neuroradiol 1996; 17:1013-1024.
38. Hitosugi M, Ichijo M, Matsuoka Y, Takenaka N, Fujii H. Proton MR spectroscopy findings in herpes simplex encephalitis. Rinsho Shinkeigaku 1996; 36:839-843.
39. Chan YL, Yeung DK, Leung SF, Cao G. Proton magnetic resonance spectroscopy of late delayed radiation-induced injury of the brain. J Magn Reson Imaging 1999; 10:130-137.
40. Gonen O, Murdoch JB, Stoyanova R, Goelman G. 3D multivoxel proton spectroscopy of human brain using a hybrid of 8th-order Hadamard encoding with 2D chemical shift imaging. Magn Reson Med 1998; 39:34-40.